• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

13-cis-retinoic acid plus interferon-alpha 2a in locally advanced squamous cell carcinoma of the cervix.

作者信息

Lippman S M, Kavanagh J J, Paredes-Espinoza M, Delgadillo-Madrueño F, Paredes-Casillas P, Hong W K, Massimini G, Holdener E E, Krakoff I H

机构信息

Department of Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston 77030.

出版信息

J Natl Cancer Inst. 1993 Mar 17;85(6):499-500. doi: 10.1093/jnci/85.6.499.

DOI:10.1093/jnci/85.6.499
PMID:8445678
Abstract
摘要

相似文献

1
13-cis-retinoic acid plus interferon-alpha 2a in locally advanced squamous cell carcinoma of the cervix.
J Natl Cancer Inst. 1993 Mar 17;85(6):499-500. doi: 10.1093/jnci/85.6.499.
2
13-cis-retinoic acid plus interferon alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervix.
J Natl Cancer Inst. 1992 Feb 19;84(4):241-5. doi: 10.1093/jnci/84.4.241.
3
Interferon-alpha 2a, 13-cis-retinoic acid and radiotherapy for locally advanced carcinoma of the cervix: a pilot study.α-2a干扰素、13-顺式维甲酸与放射疗法治疗局部晚期宫颈癌：一项初步研究。
Eur J Gynaecol Oncol. 1998;19(1):35-8.
4
Oxygenation of cervical cancers during radiotherapy and radiotherapy + cis-retinoic acid/interferon.宫颈癌在放疗及放疗联合顺式维甲酸/干扰素治疗期间的氧合作用
Int J Radiat Oncol Biol Phys. 1999 Jan 15;43(2):367-73. doi: 10.1016/s0360-3016(98)00361-7.
5
Combination of alpha-interferon 2a (alpha-IFN 2a) and 13-cis-retinoic acid (13cRA) in recurrent, pre-treated squamous-cell carcinoma of head and neck (SCCHN).α-干扰素2a（α-IFN 2a）与13-顺式维甲酸（13cRA）联合用于复发性、经预处理的头颈部鳞状细胞癌（SCCHN）。
Int J Cancer. 1997 Feb 7;70(4):491-3. doi: 10.1002/(sici)1097-0215(19970207)70:4<491::aid-ijc23>3.0.co;2-h.
6
13-cis-retinoic acid and alpha-interferon in advanced squamous cell cancer of the oesophagus.13-顺式维甲酸与α-干扰素治疗晚期食管鳞状细胞癌
Eur J Cancer. 1997 Jan;33(1):165-6. doi: 10.1016/s0959-8049(96)00362-0.
7
A phase II study of 13-cis retinoic acid plus interferon alpha-2a in advanced stage penile carcinoma: an Eastern Cooperative Oncology Group study (E3893).13-顺式维甲酸联合干扰素α-2a治疗晚期阴茎癌的II期研究：东部肿瘤协作组研究（E3893）
Cancer Invest. 2003;21(1):41-6. doi: 10.1081/cnv-120016402.
8
Prolonged stabilization of progressive squamous cell cancer of the cervix with interferon-alpha and 13-cis-retinoic acid: report of two cases and review of the literature.α-干扰素与13-顺式维甲酸对晚期子宫颈鳞状细胞癌的长期稳定作用：两例报告及文献复习
Anticancer Drugs. 1996 Sep;7(7):800-4. doi: 10.1097/00001813-199609000-00014.
9
13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin.13-顺式维甲酸与干扰素α-2a：治疗晚期皮肤鳞状细胞癌的有效联合疗法。
J Natl Cancer Inst. 1992 Feb 19;84(4):235-41. doi: 10.1093/jnci/84.4.235.
10
[13-cis retinoic acid and interferon-alfa-2a as palliative therapy in pretreated, recurrent squamous epithelial carcinoma of the cervix uteri and vulva].[13-顺式维甲酸与干扰素-α-2a作为子宫颈和外阴预处理复发性鳞状上皮癌的姑息治疗]
Geburtshilfe Frauenheilkd. 1996 Oct;56(10):520-4. doi: 10.1055/s-2007-1023277.

引用本文的文献

1
Retinoids: Molecular Aspects and Treatment in Premalignant Lesions and Cervical Cancer.类视黄醇：癌前病变和宫颈癌的分子方面和治疗方法。
Cancer Control. 2024 Jan-Dec;31:10732748241279514. doi: 10.1177/10732748241279514.
2
The use of radiosensitizing agents in the therapy of glioblastoma multiforme-a comprehensive review.多形性胶质母细胞瘤治疗中放射增敏剂的应用——全面综述。
Strahlenther Onkol. 2022 Jun;198(6):507-526. doi: 10.1007/s00066-022-01942-1. Epub 2022 May 3.
3
Phase I trial of belinostat in combination with 13-cis-retinoic acid in advanced solid tumor malignancies: a California Cancer Consortium NCI/CTEP sponsored trial.
贝林司他联合 13-顺维甲酸治疗晚期实体瘤恶性肿瘤的 I 期临床试验：加州癌症联合会 NCI/CTEP 赞助的试验。
Cancer Chemother Pharmacol. 2019 Dec;84(6):1201-1208. doi: 10.1007/s00280-019-03955-7. Epub 2019 Sep 14.
4
GRIM-19: A master regulator of cytokine induced tumor suppression, metastasis and energy metabolism.GRIM-19：细胞因子诱导的肿瘤抑制、转移和能量代谢的主要调节因子。
Cytokine Growth Factor Rev. 2017 Feb;33:1-18. doi: 10.1016/j.cytogfr.2016.09.001. Epub 2016 Sep 15.
5
Phase 2 trial of paclitaxel, 13-cis retinoic acid, and interferon alfa-2b in the treatment of advanced stage or recurrent cervical cancer.紫杉醇、13-顺式维甲酸和干扰素α-2b治疗晚期或复发性宫颈癌的2期试验。
Int J Gynecol Cancer. 2014 Nov;24(9):1636-41. doi: 10.1097/IGC.0000000000000258.
6
Peroxisome proliferator-activated receptor gamma overexpression suppresses growth and induces apoptosis in human multiple myeloma cells.过氧化物酶体增殖物激活受体γ过表达抑制人多发性骨髓瘤细胞的生长并诱导其凋亡。
Clin Cancer Res. 2008 Oct 15;14(20):6414-25. doi: 10.1158/1078-0432.CCR-08-0457.
7
Epigenetics of cervical cancer. An overview and therapeutic perspectives.宫颈癌的表观遗传学。综述与治疗前景。
Mol Cancer. 2005 Oct 25;4:38. doi: 10.1186/1476-4598-4-38.
8
Cactus pear: a natural product in cancer chemoprevention.仙人掌果：癌症化学预防中的一种天然产物。
Nutr J. 2005 Sep 8;4:25. doi: 10.1186/1475-2891-4-25.
9
Methylation and silencing of the retinoic acid receptor-beta 2 gene in cervical cancer.宫颈癌中视黄酸受体-β2基因的甲基化与沉默
BMC Cancer. 2002 Mar 21;2:4. doi: 10.1186/1471-2407-2-4.
10
Differentiating agents in pediatric malignancies: retinoids in neuroblastoma.小儿恶性肿瘤中的分化剂：神经母细胞瘤中的维甲酸
Curr Oncol Rep. 2000 Nov;2(6):511-8. doi: 10.1007/s11912-000-0104-y.